Table: Rohto -2021/22 parent results
May 12 (Reuters)-
Rohto Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2022 Mar 31, 2021 Mar 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 101.21 101.01
(-5.1 pct)
Operating 16.72 13.02
(-1.9 pct)
Recurring 17.52 12.56
(-12.6 pct)
Net 13.04 8.92
(+27.8 pct)
EPS 114.27 yen 78.20 yen
EPS Diluted 113.94 yen 77.97 yen
Ann Div 36.00 yen 28.00 yen 37.00 yen
-Q2 Div 15.00 yen 13.00 yen 18.00 yen
-Q4 Div 21.00 yen 15.00 yen 19.00 yen
NOTE - Rohto Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T